pharmaceutical-investing Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
pharmaceutical-investing Daré Bioscience announces funding award to further the development of Ovaprene
Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis
Krystal Biotech Announces FDA Clearance of IND on KB103 to Begin Enrolling Patients for the Treatment of Dystrophic Epidermolysis Bullosa
pharmaceutical-investing Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine
Alder BioPharmaceuticals Presents New 12-Month Data of Eptinezumab in PROMISE 1 Phase 3 Trial Showing Long-Term Reduction in Episodic Migraine
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
RUA GOLD Provides Exploration Update and 2026 Outlook for the Auld Creek Gold-Antimony Project, Reefton Goldfield
Juggernaut Announces Fully Funded 10,000 Meter Inaugural Drill Program on New District-Scale Gold Silver Copper Rich System at 100% Controlled Big One Property, Golden Triangle, B.C.
